Scrutiny Grows of Drug Trials Abroad Wall Street Journal - The deaths and other problems with participants in Poland, one of 10 countries involved in the 3000-patient study, have led to a delay of at least a year in ...
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval Pharmaceutical Online (press release), PA - ... treatment, and information regarding same has made cardiovascular disease the leading cause of death in China. As a leading Statin class drug, ...
Coroner details massive injuries sustained by 3 students Urbana Daily Citizen, OH - He said he found no evidence of drugs, alcohol, disease or natural death in any of the three victims. In contrast, Paul Boggs, former toxicology director of ...
Heparin taint tied to deaths Chicago Tribune, United States - Jul 30, 2008 By Bruce Japsen | Chicago Tribune reporter The US Food and Drug Administration, for the first time, has conclusively linked deaths of patients infused with ...BAX
FDA says Baxter's drug promo misleading Chicago Daily Herald, IL - Jul 30, 2008 ... of the blood-thinner heparin linked to allergic reactions and deaths. The FDA found the drug to be contaminated with a cheaper ingredient from China. ...BAX
The Chinese health care system: Lessons for other nations - WCL Hsiao - Social Science & Medicine, 1995 - Elsevier ... and physicians' behaviors one what drugs and medical ... INTRODUCTION China achieved
enviable improvement in the health ... mortality from 250 to 40 deaths per 1000 ...
Qinghaosu (artemisinin): an antimalarial drug from China - DL Klayman - Science, 1985 - sciencemag.org ... of indigenous plants used in traditional remedies as sources of drugs (2). One such ... death 390 years ago was recently com- memorated in China (5), wrote in ...
Chinese Trial on Isolated Systolic Hypertension in the Elderly - JG Wang, JA Staessen, L Gong, L Liu - Archives of Internal Medicine, 2000 - Am Med Assoc ... addition of captopril, hydrochlorothiazide, or both drugs. ... group, treatment of 1000 Chinese patients for ... 59 major cardiovascular complications, or 55 deaths. 4. ...
[BOOK] Chinese Materia Medica: Chemistry, Pharmacology and Applications YP Zhu - 1998 - books.google.com ... has also resulted in several cases of acute renal failure and one death 10 ... herbs
12 REFERENCES 1. Huang, KC (1993) The Pharmacology of Chinese Herbs, pp ... il drug. ...
Source: Google Scholar
China probes four deaths for link to drug treatment
China is investigating four deaths for links to a banned antibiotic treatment, state media reported on Tuesday, adding that more than 80 patients in 10 provinces had complained of severe adverse reactions to the drug.
Beijing last week banned the use of the Clindamycin Phosphate Glucose Injection, produced by a company in the eastern province of Anhui for treatment of bacterial infections.
Four fatalities possibly linked to the drug include a 6-year-old girl in northeastern province of Heilongjiang who died after using the drug, and a 63-year-old woman from northwestern province of Shaanxi who suffered a severe adverse reaction while receiving the injection and died two days later, the official China Daily reported.
An increasing number of patients nationwide, mostly from rural areas, have complained about the symptoms ranging from chest and stomach pain, diarrhea, nausea to anaphylactic shock, after being injected with the drug, the newspaper said.
The use of fake and poor-quality products has killed dozens of people in China in recent years and has sparked widespread public fury about food and drug safety. Chinese media have blamed the frequent scandals on businesses obsessed with making profits and on lax official supervision.
The drug watchdog, State Food and Drug Administration, has sent an investigative team to search for links between the injections and the deaths, according to the newspaper.
More than 10 patients who had adverse reactions to the drug are receiving medical treatment, the paper reported.
Months earlier, local media exposed a bogus drug scandal that had killed 11 people in the southern province of Guangdong after they received injections of fake Armillarisni-A made by a Heilongjiang company, whose executives were detained and its license withdrawn.
